| Members |
acceptabilityId |
| 5-Hydroxytryptamine-3-receptor antagonist overdose of undetermined intent (disorder) |
Preferred (foundation metadata concept) |
| 5-Hydroxytryptamine-3-receptor antagonist poisoning |
Acceptable (foundation metadata concept) |
| 5-Hydroxytryptamine-3-receptor antagonist poisoning (disorder) |
Preferred (foundation metadata concept) |
| 5-Hydroxytryptamine-3-receptor antagonist poisoning of undetermined intent |
Acceptable (foundation metadata concept) |
| 5-Hydroxytryptamine-3-receptor antagonist poisoning of undetermined intent (disorder) |
Preferred (foundation metadata concept) |
| 5-Hydroxytryptophan measurement |
Preferred (foundation metadata concept) |
| 5-Hydroxytryptophan measurement (procedure) |
Preferred (foundation metadata concept) |
| 5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase |
Preferred (foundation metadata concept) |
| 5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase (substance) |
Preferred (foundation metadata concept) |
| 5-O-(4-coumaroyl)-D-quinate/shikimate 3'-hydroxylase |
Acceptable (foundation metadata concept) |
| 5-OH indole acetic acid (& level (& urine)) |
Preferred (foundation metadata concept) |
| 5-OH indole acetic acid (& level (& urine)) |
Preferred (foundation metadata concept) |
| 5-OH indole acetic acid (& level (& urine)) (procedure) |
Preferred (foundation metadata concept) |
| 5-OH indole acetic acid (& level (& urine)) (procedure) |
Preferred (foundation metadata concept) |
| 5-Oxoprolinase deficiency |
Preferred (foundation metadata concept) |
| 5-Oxoprolinase deficiency (disorder) |
Preferred (foundation metadata concept) |
| 5-Oxoproline |
Preferred (foundation metadata concept) |
| 5-Oxoproline (substance) |
Preferred (foundation metadata concept) |
| 5-Oxoproline + pipecolate |
Preferred (foundation metadata concept) |
| 5-Oxoproline + pipecolate (substance) |
Preferred (foundation metadata concept) |
| 5-Oxoproline measurement |
Preferred (foundation metadata concept) |
| 5-Oxoproline measurement (procedure) |
Preferred (foundation metadata concept) |
| 5-Oxoprolinuria |
Acceptable (foundation metadata concept) |
| 5-WAY LEPTOSPIROSIS VACCINE |
Preferred (foundation metadata concept) |
| 5-WAY LEPTOSPIROSIS VACCINE (product) |
Preferred (foundation metadata concept) |
| 5-alpha reductase deficiency |
Acceptable (foundation metadata concept) |
| 5-alpha reductase inhibitor |
Preferred (foundation metadata concept) |
| 5-alpha reductase inhibitor |
Preferred (foundation metadata concept) |
| 5-alpha reductase inhibitor (disposition) |
Preferred (foundation metadata concept) |
| 5-alpha reductase inhibitor-containing product |
Preferred (foundation metadata concept) |
| 5-alpha tetrahydro-11-dehydrocorticosterone |
Preferred (foundation metadata concept) |
| 5-alpha tetrahydro-11-dehydrocorticosterone (substance) |
Preferred (foundation metadata concept) |
| 5-alpha-Tetrahydrocortisol measurement |
Preferred (foundation metadata concept) |
| 5-alpha-Tetrahydrocortisol measurement (procedure) |
Preferred (foundation metadata concept) |
| 5-alpha-dihydrotestosterone |
Acceptable (foundation metadata concept) |
| 5-alpha-tetrahydrocortisol |
Preferred (foundation metadata concept) |
| 5-alpha-tetrahydrocortisol (substance) |
Preferred (foundation metadata concept) |
| 5-amino-4-imidazole carboxamide ribosiduria |
Preferred (foundation metadata concept) |
| 5-amino-4-imidazole carboxamide ribosiduria (disorder) |
Preferred (foundation metadata concept) |
| 5-amino-6-(5-phosphoribosylamino) uracil reductase |
Preferred (foundation metadata concept) |
| 5-amino-6-(5-phosphoribosylamino) uracil reductase (substance) |
Preferred (foundation metadata concept) |
| 5-aminolevulinate |
Preferred (foundation metadata concept) |
| 5-aminolevulinate (substance) |
Preferred (foundation metadata concept) |
| 5-aminolevulinate dehydratase |
Acceptable (foundation metadata concept) |
| 5-aminolevulinate synthase |
Preferred (foundation metadata concept) |
| 5-aminolevulinate synthase (substance) |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid (substance) |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid hydrochloride |
Acceptable (foundation metadata concept) |
| 5-aminolevulinic acid only product |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid only product in cutaneous dose form |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid only product in oral dose form |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid-containing product |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid-containing product in cutaneous dose form |
Preferred (foundation metadata concept) |
| 5-aminolevulinic acid-containing product in oral dose form |
Preferred (foundation metadata concept) |
| 5-aminopentanamidase |
Preferred (foundation metadata concept) |
| 5-aminopentanamidase (substance) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid |
Acceptable (foundation metadata concept) |
| 5-aminosalicylic acid |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid (substance) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid adverse reaction |
Acceptable (foundation metadata concept) |
| 5-aminosalicylic acid adverse reaction (disorder) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid allergy |
Acceptable (foundation metadata concept) |
| 5-aminosalicylic acid allergy |
Acceptable (foundation metadata concept) |
| 5-aminosalicylic acid overdose |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid overdose (disorder) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid overdose of undetermined intent |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid overdose of undetermined intent (disorder) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid poisoning |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid poisoning (disorder) |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid poisoning of undetermined intent |
Preferred (foundation metadata concept) |
| 5-aminosalicylic acid poisoning of undetermined intent (disorder) |
Preferred (foundation metadata concept) |
| 5-aminovaleramidase |
Acceptable (foundation metadata concept) |
| 5-aminovalerate aminotransferase |
Preferred (foundation metadata concept) |
| 5-aminovalerate aminotransferase (substance) |
Preferred (foundation metadata concept) |
| 5-azacytidine |
Preferred (foundation metadata concept) |
| 5-azacytidine (substance) |
Preferred (foundation metadata concept) |
| 5-beta-pregnane-3-alpha,11-beta,17,20-alpha,21-pentol |
Acceptable (foundation metadata concept) |
| 5-beta-pregnane-3-alpha,11-beta,17,20-beta,21-pentol |
Acceptable (foundation metadata concept) |
| 5-carboxymethyl-2-hydroxymuconate delta-isomerase |
Preferred (foundation metadata concept) |
| 5-carboxymethyl-2-hydroxymuconate delta-isomerase (substance) |
Preferred (foundation metadata concept) |
| 5-chloro-2-methyl-4-isothiazolin-3-one |
Preferred (foundation metadata concept) |
| 5-chloro-2-methyl-4-isothiazolin-3-one (substance) |
Preferred (foundation metadata concept) |
| 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one kathon (3:1 in water) |
Preferred (foundation metadata concept) |
| 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one kathon (3:1 in water) (substance) |
Preferred (foundation metadata concept) |
| 5-dehydro-2-deoxygluconokinase |
Preferred (foundation metadata concept) |
| 5-dehydro-2-deoxygluconokinase (substance) |
Preferred (foundation metadata concept) |
| 5-dehydro-4-deoxyglucarate dehydratase |
Preferred (foundation metadata concept) |
| 5-dehydro-4-deoxyglucarate dehydratase (substance) |
Preferred (foundation metadata concept) |
| 5-deoxyadenosylcobalamin |
Acceptable (foundation metadata concept) |
| 5-flucytosine level |
Acceptable (foundation metadata concept) |
| 5-fluorocytosine |
Acceptable (foundation metadata concept) |
| 5-fluorouracil |
Acceptable (foundation metadata concept) |
| 5-formyltetrahydrofolate cyclo-ligase |
Preferred (foundation metadata concept) |
| 5-formyltetrahydrofolate cyclo-ligase (substance) |
Preferred (foundation metadata concept) |
| 5-guanidino-2-oxopentanoate decarboxylase |
Preferred (foundation metadata concept) |
| 5-guanidino-2-oxopentanoate decarboxylase (substance) |
Preferred (foundation metadata concept) |
| 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid |
Preferred (foundation metadata concept) |
| 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid (substance) |
Preferred (foundation metadata concept) |
| 5-hydroxy tryptamine |
Acceptable (foundation metadata concept) |
| 5-hydroxy tryptophan |
Acceptable (foundation metadata concept) |
FHIR